Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Ensysce Biosciences Inc. Receives Small Business Grant from NIH to Optimize Single Walled Carbon Nanotube Formulation for Therapeutic Delivery of siRNA

Abstract:
Ensysce Biosciences Inc. announced today they have received a SBIR award of roughly $300,000 to optimize the formulation of their single walled carbon nanotube (SWCNT)/siRNA complex for therapeutic delivery. These funds, along with the recent $1 million dollars that were raised in June and the State of Texas Emerging Technology Funds that had been awarded previously, will allow the finalization of the formulation prior to undertaking Investigational New Drug (IND) enabling studies.

Ensysce Biosciences Inc. Receives Small Business Grant from NIH to Optimize Single Walled Carbon Nanotube Formulation for Therapeutic Delivery of siRNA

Houston, TX | Posted on September 26th, 2012

siRNA is one of the most intriguing and promising approaches to cancer therapy, but adequate cellular delivery has been an issue. The SBIR award will aid the preclinical development of this ground breaking delivery technology. With completion of the studies, the Ensysce product will be poised to complete an IND application and bring SWCNT delivery of siRNA rapidly into clinical development.

Carbon nanotubes provide a means to deliver unmodified, large active molecular agents through natural barriers within the body and specifically into cancer cells. "The siRNA delivery into tumors by SWCNT and biological activity have been conclusively and repeatedly demonstrated in our animal studies. With the finalization of our formulation, our drug product will be taken through late preclinical development into human studies," said Dr. Kirkpatrick, CEO of Ensysce. "The studies funded by the NIH will complete the last stage of our product selection and we will move in to the safety studies required by the FDA to enter clinical trials."

Ensysce is located in the Biotechnology Commercialization Center in the Texas Medical Center, a site that aids its research collaborations with Rice University. "The research by Ensysce continues to demonstrate the utility of this approach for siRNA delivery," said Dr. R. Bruce Weisman, Professor of Chemistry at Rice University. "Ensysce is leading the way in showing that carbon nanotubes can effectively deliver these macromolecules and provide biological activity in tumor models."

####

About Ensysce Biosciences Inc.
Ensysce Biosciences, a Houston, TX-based nanotechnology company, is focused on the use of carbon nanotubes for therapeutics in the area of cancer treatment. The company has an extensive carbon nanotube-related, worldwide intellectual property portfolio, including IP developed at Rice University by the late Nobel Prize winner Dr. Rick Smalley.

For more information, please click here

Contacts:
Ensysce Biosciences Inc.
Dr. D. Lynn Kirkpatrick
713-790-0080

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Flexible electronics integrated with paper-thin structure for use in space January 17th, 2025

‘Brand new physics’ for next generation spintronics: Physicists discover a unique quantum behavior that offers a new way to manipulate electron-spin and magnetization to push forward cutting-edge spintronic technologies, like computing that mimics the human brain January 17th, 2025

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025

How a milk component could eliminate one of the biggest challenges in treating cancer and other disease, including rare diseases: Nebraska startup to use nanoparticles found in milk to target therapeutics to specific cells January 17th, 2025

Govt.-Legislation/Regulation/Funding/Policy

Department of Energy announces $71 million for research on quantum information science enabled discoveries in high energy physics: Projects combine theory and experiment to open new windows on the universe January 17th, 2025

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025

Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025

Researchers uncover strong light-matter interactions in quantum spin liquids: Groundbreaking experiment supported by Rice researcher reveals new insights into a mysterious phase of quantum matter December 13th, 2024

Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings

Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025

Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024

Catalytic combo converts CO2 to solid carbon nanofibers: Tandem electrocatalytic-thermocatalytic conversion could help offset emissions of potent greenhouse gas by locking carbon away in a useful material January 12th, 2024

TU Delft researchers discover new ultra strong material for microchip sensors: A material that doesn't just rival the strength of diamonds and graphene, but boasts a yield strength 10 times greater than Kevlar, renowned for its use in bulletproof vests November 3rd, 2023

Announcements

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025

How a milk component could eliminate one of the biggest challenges in treating cancer and other disease, including rare diseases: Nebraska startup to use nanoparticles found in milk to target therapeutics to specific cells January 17th, 2025

The National Space Society Congratulates SpaceX on Starship’s 7th Test Flight: Latest Test of the Megarocket Hoped to Demonstrate a Number of New Technologies and Systems January 17th, 2025

The National Space Society Congratulates Blue Origin on the Inaugural Flight of New Glenn: The Heavy Lift Reusable Rocket Will Open New Frontiers and Provide Healthy Competition January 17th, 2025

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Researchers uncover strong light-matter interactions in quantum spin liquids: Groundbreaking experiment supported by Rice researcher reveals new insights into a mysterious phase of quantum matter December 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project